Grand Medical (Europe)

Galileilaan 15
2845 Niel
BE
Grand Medical (Europe)
Foundation date
16/04/2021
Sector
#PharmaSubsector
- #Therapeutics - Peptides
- #Therapeutics - Proteins
- #Other - Industrial Biotechnology
- #Pharma - Anti-infectives
- #Pharma - Gene therapy
- #Pharma - Generics
- #Pharma - Small molecule therapeutics
- #Pharma - Vaccines
Therapeutic areas
- #Cardiovascular
- #Conditions originating in the perinatal period
- #Digestive system
- #Neoplasms / cancer / oncology
- #Respiratory system
Grand Medical Europe (GME) is a newly established Belgian subsidiary of China Grand Pharmaceutical & Healthcare Holdings Limited (CGP). CGP ranks among China top Pharma and develops products and medical devices in respiratory, cardio/cerebrovascular, antiviral, anti-infection, oncology, ophthalmology, ENT, amino acids, CNS fields. GME is focusing on R&D collaboration with Belgian & European institutions and wishes to explore commercial cooperation with companies interested in the Chinese market.
Upcoming events
All events-
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB -
1212 '23
BioFIT 2023
Event by: Eurasanté
Latest news
More news-
argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis
Thursday September 21st 2023
Read more
-
Galapagos appoints Simon Sturge to its Board of Directors
Tuesday September 19th 2023
Read more
-
13th Investment for HERAN Partners: Broken String Biosciences (UK)
Tuesday September 19th 2023
Read more
Jobs
More jobs-
-
-
23/09/23
East Flanders
ERC-funded postdoc position on inter-organelle communication during plant biotic stress responses
Permanent
VIB